This compound was developed as an inhibitor of the PDE10A enzyme, which plays an important role in the central nervous system, particularly in brain regions involved in motor control and neural functions related to behavior and emotions. Therefore, it has potential for use as a drug for treating psychiatric disorders such as schizophrenia, depression, and disorders related to motor control such as Huntington's disease.

Laboratory and animal studies have shown that this substance can cross the blood-brain barrier effectively, allowing it to act on the brain efficiently. Additionally, it has high specificity for the target, which helps reduce side effects that may arise from broadly acting substances.

In research, this substance is used as a pharmacological tool to study the role of PDE10A in neuronal cell signaling pathways and to evaluate the potential of the PDE10A inhibitor class in treating neurological disorders in the future.